Latest news
Loading news…
Canget BioTekpharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Buffalo, New York, United States Founded 2012 1-10 employees For Profit
Canget BioTekpharma is a biotech and biopharma company used to develop novel, cancer-targeting anticancer agents.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Patents
5
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 5
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2012
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 2
- HQ
- Buffalo, New York, United States
- Region
- Great Lakes, East Coast, Northeastern US
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.1
- Trend (90d)
- -0.2
Key People at Canget BioTekpharma
Chief Medical Officer
Acting CEO
Founder & Chief Scientific Officer
2
professional contacts at Canget BioTekpharma
Contact execs at Canget BioTekpharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Canget BioTekpharma
Loading news…
FAQs about Canget BioTekpharma
People who checked this page also checked these
Browse the full Acquirezy directory.